一个新的超图模型用于识别和优先考虑癌症个性化驱动因素
Naiqian Zhang1, Fubin Ma1, Dong Guo1,2
1School of Mathematics and Statistics, Shandong University, Weihai, China.
PLoS computational biology
|April 29, 2024
概括
识别个性化癌症驱动基因对于有效治疗至关重要. 一种新的方法,PDRWH,通过分析患者群体的下游影响来优先考虑突变基因,改善瘤分层和个性化治疗.
科学领域:
- 基因组学就是基因组学.
- 计算生物学 计算生物学
- 在瘤学瘤学.
背景情况:
- 癌症的发展涉及驱动突变赋予增长优势,而大多数突变是乘客.
- 识别驱动基因是有效的癌症治疗的关键,但患者异质性给当前的方法带来了挑战.
- 现有的计算方法经常提供队列级驱动器基因列表,忽略了个体患者的变异.
研究的目的:
- 引入一种新的计算方法,PDRWH,以优先考虑个性化的驱动基因在癌症中.
- 通过考虑下游基因表达影响来解决识别个体特异性驱动突变的挑战.
- 改善瘤分层和推进个性化癌症治疗策略.
主要方法:
- 在单个患者中,PDRWH优先考虑突变基因.
- 它分析了这些基因对患者群体的下游基因表达的影响,这些患者群体具有共同的共同突变和表达特征.
- 该方法在16个TCGA癌症数据集上进行了评估,并与现有的队列级和个人级方法进行了比较.
主要成果:
- PDRWH成功地确定了已知的一般性和瘤特异性驱动基因.
- 该方法在五种癌症类型中优于现有的个人层面和队列层面的方法.
- PDRWH确定了常见和罕见的驱动基因,证明了其捕获多种突变模式的能力.
- 实验验证证了预测的驱动基因在促进瘤细胞增殖中的作用.
结论:
- 在癌症中,PDRWH提供了个性化驱动基因识别的强大方法.
- 由PDRWH生成的个性化驾驶员配置文件可以增强瘤分层和对瘤异质性的理解.
- 这些发现支持PDRWH在开发个性化癌症治疗方面有很大贡献的潜力.
更多相关视频
09:53Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography
Published on: August 16, 2020
7.2K
07:41Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
9.0K
相关概念视频
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
01:21Cancer Survival Analysis
345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345
02:26Protein Networks
3.9K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
3.9K
02:43Mouse Models of Cancer Study
5.5K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.5K